Leonard P. Guarente

Leonard Pershing Guarente (born 1952) is an American biologist best known for his research on life span extension in the budding yeast Saccharomyces cerevisiae, roundworms (Caenorhabditis elegans), and mice.[2][3] He is a Novartis Professor of Biology at the Massachusetts Institute of Technology.[4]

Leonard P. Guarente
Born1952 (age 67–68)[1]
Revere, Massachusetts[1]
Alma materHarvard University
Websiteweb.mit.edu/biology/guarente/

Early life and education

Leonard Guarente was born and raised in Revere, Massachusetts and was the first person in his family to attend college, when he started his undergraduate work at MIT in 1970.[5] He earned his PhD at MIT, studying under Jon Beckwith and Mark Ptashne.[6] and he did a post doc at Harvard.[7]

Science

MIT hired Guarente and he opened his own lab in 1981;[6] he won tenure there in 1986.[5] For the first nine years, his lab studied gene regulation in yeast.[5][6]

In 1991 his lab started to study genes involved in aging.[5] In 1993, Cynthia Kenyon's lab at UCSF discovered that a single-gene mutation in (Daf-2) could double the lifespan of C. elegans. That same year, David Sinclair joined the Guarente lab, and they developed the hypothesis that caloric restriction slows aging by activation of sirtuins.[8] The Kenyon and Guarente labs came to lead the field studying the genetics of aging.[9]

In 1995 the Guarente lab identified the gene SIR4 (Silent information regulator 4) as a longevity regulator. When SIRT4 was mutated in a single cell organism S. cerevisiae longevity was extended.[10] It was later determined that the complex of SIR2 and SIR4 are responsible for longevity phenotype,[11] and that over-expression of SIR2 alone was sufficient to extend lifespan. Moreover, scientists in Guarente laboratory determined that SIR2 is necessary for longevity extension by calorie restriction.[12]

In 1999, Guarente and Kenyon became co-founders of Elixir Pharmaceuticals, which aimed to develop drugs targeting sirtuin;[8] Guarente left the company seven years later after he disagreed with venture capitalists who had gained control of the company about the focus of the company.[13]

In 2000 the Guarente laboratory published work identifying SIR2's activity as a NAD+-dependent protein deacetylase. This NAD dependence explained how SIR2 could connect diet to physiology and suggested the mechanism by which calorie restriction could extend the lifespan of some organisms.[14]

Guarente made the case that involvement of SIR2 in metabolism and lifespan is conserved in other organisms. In round worm, Guarente reported that Caenorhabditis elegans, expression of SIR2 (sir2.1) is sufficient to extend longevity[15] and in the fruit fly, Drosophila melanogaster, overexpression of SIR2 was also reported to extended lifespan.[16] However, other groups have disputed this finding and showed that SIR2-expression does not cause lifespan extension in worms or flies.[17] Overexpression of SIRT1 (mammalian sir2 homolog) does not extend lifespan.[18] Several of Guarente's high profile publications on SIRT1 have been retracted or corrected.[19]

Guarente wrote an autobiography in 2003 titled Ageless Quest: One Scientist's Search for Genes That Prolong Youth.

Guarente's rivalry with Sinclair, which began in 2002 when Sinclair challenged Guarante's description of how sir2 might be involved in aging at a scientific meeting at Cold Spring Harbor Laboratory, was the subject of an article in Science in 2004.[20]

In 2014 Guarente co-founded the dietary supplement company Elysium Health.[13][21]

gollark: No, like I said, there is basically no data gathering.
gollark: No, you can read the public skynet logs, it doesn't actually send any unless it's explicitly queried.
gollark: For 5000KST/i!
gollark: PotatOS (without extended monitoring on; it's off by default) doesn't actually log anything.
gollark: No, actually.

References
  1. Bolino, August C. (2012). Men of Massachusetts: Bay State Contributors to American Society. p. 426. ISBN 978-1475933765.
  2. "Popular paper by famous longevity researcher gets mega-correction". Retraction Watch. 2016-03-08. Retrieved 2017-08-13.
  3. "Leonard Guarente". Big Think. Retrieved 2017-08-13.
  4. "Leonard P. Guarente | MIT Biology". biology.mit.edu. Retrieved 2017-08-13.
  5. Trafton, Anne (September 15, 2009). "In Profile: Leonard Guarente". MIT News Office.
  6. Wade, Nicholas (26 September 2000). "Scientist at Work: Leonard Guarente; Searching for Genes to Slow the Hands of Biological Time". The New York Times.
  7. Johnson, Thomas E. (April 2004). "Book Reviews: The Start of Anti-Aging Medicine?". The Gerontologist. 44 (2): 270–273. doi:10.1093/geront/44.2.270. ISSN 1758-5341.
  8. Duncan, David Ewing (August 15, 2007). "The Enthusiast". MIT Technology Review.
  9. Solomon, Lewis D. (2017). The Quest for Human Longevity: Science, Business, and Public Policy. Routledge. ISBN 9781351475594.
  10. Kennedy, B.K.; et al. (1995). "Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae". Cell. 80 (3): 485–96. doi:10.1016/0092-8674(95)90499-9. PMID 7859289.
  11. Kaeberlein, M., M. McVey, and L. Guarente (1999). "The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms". Genes Dev. 13 (19): 2570–80. doi:10.1101/gad.13.19.2570. PMC 317077. PMID 10521401.CS1 maint: multiple names: authors list (link)
  12. Lin, S.J., P.A. Defossez, and L. Guarente (2000). "Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae". Science. 289 (5487): 2126–8. Bibcode:2000Sci...289.2126L. doi:10.1126/science.289.5487.2126. PMID 11000115.CS1 maint: multiple names: authors list (link)
  13. Wallace, Benjamin. "An MIT Scientist Claims That This Pill Is the Fountain of Youth". New York Magazine.
  14. Imai, S.; et al. (2000). "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase". Nature. 403 (6771): 795–800. Bibcode:2000Natur.403..795I. doi:10.1038/35001622. PMID 10693811.
  15. Tissenbaum, H.A.; L. Guarente (2001). "Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans". Nature. 410 (6825): 227–30. Bibcode:2001Natur.410..227T. doi:10.1038/35065638. PMID 11242085.
  16. Rogina, B.; S.L. Helfand (2004). "Sir2 mediates longevity in the fly through a pathway related to calorie restriction". Proc Natl Acad Sci U S A. 101 (45): 15998–6003. Bibcode:2004PNAS..10115998R. doi:10.1073/pnas.0404184101. PMC 528752. PMID 15520384.
  17. Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Somogyvári, Milán; Piper, Matthew D.; Hoddinott, Matthew; Sutphin, George L.; Leko, Vid (2011-09-21). "Absence of effects of Sir2 over-expression on lifespan in C. elegans and Drosophila". Nature. 477 (7365): 482–485. Bibcode:2011Natur.477..482B. doi:10.1038/nature10296. ISSN 0028-0836. PMC 3188402. PMID 21938067.
  18. Bordone, L.; et al. (2007). "SIRT1 transgenic mice show phenotypes resembling calorie restriction". Aging Cell. 6 (6): 759–67. doi:10.1111/j.1474-9726.2007.00335.x. PMID 17877786.
  19. Palus, Author Shannon (2016-03-08). "Popular paper by famous longevity researcher gets mega-correction". Retraction Watch. Retrieved 2019-04-02.
  20. Couzin, J (27 February 2004). "Scientific community. Aging research's family feud". Science. 303 (5662): 1276–9. doi:10.1126/science.303.5662.1276. PMID 14988530.
  21. Ramsey, Lydia. "A startup that's developed an anti-aging supplement just raised $20 million". Business Insider.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.